IMU 4.00% 4.8¢ imugene limited

Check-vacc - possible complete response case study!, page-22

  1. 842 Posts.
    lightbulb Created with Sketch. 198
    I am sure and hope there are already really smart people working on ways to differentiate 'pseudoprogression' from 'progressive disease' since decisions on further treatment choices/path could be 'costly' due to the 'mis interpretation' based on current diagnosis/monitoring/tracking methodologies.
    The science and its application are still evolving.
    As usual, resources and money...
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.